Imugene (IUGNF) Income Statement
Imugene Income Statement
Last quarter (Q4 2026), Imugene's total revenue was $0.00, an increase of 100.00% from the same quarter last year. In Q4, Imugene's net income was $-67.52M. See Imugene’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| $ 0.00 | $ 4.40M | $ 4.97M | $ 11.78M | $ 12.97M | |
| $ -6.84M | $ 4.40M | $ 4.97M | $ 9.57M | $ 10.56M | |
| $ 68.11M | $ 75.34M | $ 135.09M | $ 51.29M | $ 50.67M | |
| Depreciation and Amortization | $ 6.84M | $ 3.38M | $ 5.84M | $ 2.20M | $ 2.41M |
| $ -68.11M | $ -66.68M | $ -147.98M | $ -47.43M | $ -48.06M | |
| $ -74.95M | $ -70.94M | $ -140.93M | $ -51.29M | $ -50.67M | |
| $ -32.38M | $ 1.92M | $ -13.37M | $ 1.64M | $ 189.84K | |
| $ -107.34M | $ -69.02M | $ -154.30M | $ -49.66M | $ -50.48M | |
| $ -105.34M | $ -69.02M | $ -149.68M | $ -37.91M | $ -37.87M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.32 | $ -0.32 | $ -0.72 | $ -0.21 | $ -0.23 |
| Diluted EPS | $ -0.32 | $ -0.32 | $ -0.72 | $ -0.21 | $ -0.23 |
| Weighted Average Shares Outstanding | 326.10M | 218.70M | 208.49M | 184.58M | 165.80M |
| Weighted Average Shares Outstanding (Diluted) | 326.10M | 218.70M | 208.49M | 184.58M | 165.80M |
Currency in AUD